XML 79 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments (Tables)
3 Months Ended
Apr. 01, 2012
Information about Certain Financial Assets and Liabilities
Information about certain of our financial assets and liabilities follows:
(millions of dollars)
 
April 1,
2012
   
Dec. 31,
2011
 
Selected financial assets measured at fair value on a recurring basis(a) :
           
Trading securities(b)
  $ 138     $ 154  
Available-for-sale debt securities(c)
    27,855       29,179  
Available-for-sale money market funds(d)
    1,639       1,727  
Available-for-sale equity securities, excluding money market funds(c)
    371       317  
Derivative financial instruments in receivable positions(e):
               
Interest rate swaps
    825       1,033  
Foreign currency forward-exchange contracts
    240       349  
Foreign currency swaps
    93       17  
Total
    31,161       32,776  
Other selected financial assets(f):
               
Held-to-maturity debt securities, carried at amortized cost(c)
    1,591       1,587  
Private equity securities, carried at equity method or at cost(g)
    1,010       1,020  
Total
    2,601       2,607  
Total selected financial assets
  $ 33,762     $ 35,383  
 
Financial liabilities measured at fair value on a recurring basis(a):
               
Derivative financial instruments in a liability position(h):
               
Foreign currency swaps
  $ 539     $ 1,396  
Foreign currency forward-exchange contracts
    278       355  
Interest rate swaps
    26       14  
Total
    843       1,765  
Other financial liabilities(i):
               
Short-term borrowings, carried at historical proceeds, as adjusted(f)
    5,526       4,018  
Long-term debt, carried at historical proceeds, as adjusted(j), (k)
    33,543       34,931  
Total
    39,069       38,949  
Total selected financial liabilities
  $ 39,912     $ 40,714  
(a)
We use a market approach in valuing financial instruments on a recurring basis. See also Note 1C. Basis of Presentation and Significant Accounting Policies: Fair Value. All of our financial assets and liabilities measured at fair value on a recurring basis use Level 2 inputs in the calculation of fair value, except that included in available-for-sale equity securities, excluding money market funds, are $131 million as of April 1, 2012 and $85 million as of December 31, 2011 of investments that use Level 1 inputs in the calculation of fair value, and $16 million as of April 1, 2012 and $25 million as of December 31, 2011 that use Level 3 inputs.
(b)
Trading securities are held in trust for legacy business acquisition severance benefits.
(c)
Gross unrealized gains and losses are not significant.
(d)
Includes approximately $625 million as of April 1, 2012 and December 31, 2011 of money market funds held in escrow to secure certain of Wyeth’s payment obligations under its 1999 Nationwide Class Action Settlement Agreement, which relates to litigation against Wyeth concerning its former weight-loss products, Redux and Pondimin. The amount also includes $372 million as of April 1, 2012 and $357 million as of December 31, 2011 of money market funds held in trust in connection with the asbestos litigation involving Quigley Company, Inc., a wholly owned subsidiary.
(e)
Designated as hedging instruments, except for certain foreign currency contracts used as offsets; namely, foreign currency forward-exchange contracts with fair values of $123 million and foreign currency swaps with fair values of $16 million at April 1, 2012; and foreign currency forward-exchange contracts with fair values of $169 million and interest rate swaps with fair values of $8 million at December 31, 2011.
(f)
The differences between the estimated fair values and carrying values of these financial assets and liabilities not measured at fair value on a recurring basis were not significant as of April 1, 2012 or December 31, 2011. Held-to-maturity debt securities and our short-term and long-term debt fair value are based on Level 2 valuations using a market approach. Fair value measurements for private equity securities are based on Level 3 valuations using a market approach.
(g)
Our private equity securities represent investments in the life sciences sector.
(h)
Designated as hedging instruments, except for certain foreign currency contracts used as offsets; namely, foreign currency forward-exchange contracts with fair values of $190 million and foreign currency swaps with fair values of $99 million at April 1, 2012; and foreign currency forward-exchange contracts with fair values of $141 million and foreign currency swaps with fair values of $123 million at December 31, 2011.
(i)
Some carrying amounts may include adjustments for discount or premium amortization or for the effect of interest rate swaps designated as hedges.
(j)
Includes foreign currency debt with fair values of $855 million at April 1, 2012 and $919 million at December 31, 2011, which are used as hedging instruments.
(k)
The fair value of our long-term debt is $38.6 billion at April 1, 2012 and $40.1 billion at December 31, 2011.
Selected Financial Assets and Liabilities Presented in the Condensed Consolidated Balance Sheets
These selected financial assets and liabilities are presented in the Condensed Consolidated Balance Sheets as follows:
(millions of dollars)
 
April 1,
2012
   
Dec. 31,
2011
 
Assets:
           
Cash and cash equivalents
  $ 934     $ 900  
Short-term investments
    21,038       23,270  
Long-term investments
    10,632       9,814  
Taxes and other current assets(a)
    294       357  
Taxes and other noncurrent assets(b)
    864       1,042  
Total
  $ 33,762     $ 35,383  
Liabilities:
               
Short-term borrowings, including current portion of long-term debt
  $ 5,526     $ 4,018  
Other current liabilities(c)
    283       459  
Long-term debt
    33,543       34,931  
Other noncurrent liabilities(d)
    560       1,306  
Total
  $ 39,912     $ 40,714  
(a)
As of April 1, 2012, derivative instruments at fair value include foreign currency forward-exchange contracts ($240 million), foreign currency swaps ($33 million) and interest rate swaps ($21 million) and, at December 31, 2011, include foreign currency forward-exchange contracts ($349 million) and interest rate swaps ($8 million).
(b)
As of April 1, 2012, derivative instruments at fair value include interest rate swaps ($804 million) and foreign currency swaps ($60 million) and, at December 31, 2011, include interest rate swaps ($1.0 billion) and foreign currency swaps ($17 million).
(c)
At April 1, 2012, derivative instruments at fair value include foreign currency forward-exchange contracts ($278 million) and foreign currency swaps ($5 million) and, at December 31, 2011, include foreign currency forward-exchange contracts ($355 million) and foreign currency swaps ($104 million).
(d)
At April 1, 2012, derivative instruments at fair value include foreign currency swaps ($534 million) and interest rate swaps ($26 million) and, at December 31, 2011, include foreign currency swaps ($1.3 billion) and interest rate swaps ($14 million).
Contractual Maturities of Available-for-sale and Held-to-maturity Debt Securities
The contractual maturities of the available-for-sale and held-to-maturity debt securities follow:
   
Years
       
(millions of dollars)
 
Within 1
   
Over 1
to 5
   
Over 5
to 10
   
Total as of
April 1,
2012
 
Available-for-sale debt securities:
                       
Western European, Scandinavian and other government debt
  $ 9,744     $ 1,567     $ ––     $ 11,311  
Corporate debt(a)
    2,606       2,546       382       5,534  
U.S. Government debt
    4,395       ––       257       4,652  
Western European, Scandinavian and other government agency debt
    2,195       305       ––       2,500  
Federal Home Loan Mortgage Corporation and Federal National
Mortgage Association asset-backed securities
    ––       2,270       1       2,271  
Supranational debt
    1,149       438       ––       1,587  
Held-to-maturity debt securities:
                               
Certificates of deposit and other
    1,202       381       8       1,591  
Total debt securities
  $ 21,291     $ 7,507     $ 648     $ 29,446  
(a)
Largely issued by above-investment-grade institutions in the financial services sector.
Schedule of Gains/(Losses) Incurred to Hedge or Offset Operational Foreign Exchange or Interest Rate Risk
Information about the gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk follows:
   
Amount of
Gains/(Losses)
Recognized in OID(a) (b) (c)
   
Amount of
Gains/(Losses)
Recognized in OCI
(Effective Portion)(a) (d)
   
Amount of
Gains/(Losses)
Reclassified from
OCI into OID
(Effective Portion)(a) (d)
 
(millions of dollars)
 
April 1,
2012
   
April 3,
2011
   
April 1,
2012
   
April 3,
2011
   
April 1,
2012
   
April 3,
2011
 
Three Months Ended
                                   
                                     
Derivative Financial Instruments in Cash
Flow Hedge Relationships
                                   
Foreign currency swaps
  $ ––     $ ––     $ 428     $ 305     $ 300     $ 506  
                                                 
Derivative Financial Instruments in Net
Investment Hedge Relationships
                                               
Foreign currency swaps
  (1 )   2     125     33     ––     ––  
                                                 
Derivative Financial Instruments Not
Designated as Hedges
                                               
Foreign currency forward-exchange contracts
    (127 )     (197 )     ––       ––       ––       ––  
Foreign currency swaps
  (23 )   30     ––     ––     ––     ––  
                                                 
Non-Derivative Financial Instruments in
Net Investment Hedge Relationships
                                               
Foreign currency short-term borrowings
    ––       ––       ––       43       ––       ––  
Foreign currency long-term debt
  ––     ––     50     28     ––     ––  
All other net
    (1 )     (1 )     9       2       ––       4  
Total
  $ (152 )   $ (166 )   $ 612     $ 411     $ 300     $ 510  
(a)
OID = Other (income)/deductions—net, included in the income statement account, Other deductions—net. OCI = Other comprehensive income/(loss), included in the balance sheet account Accumulated other comprehensive loss.
(b)
Also includes gains and losses attributable to the hedged risk in fair value hedge relationships.
(c)
There was no significant ineffectiveness in the first quarters of 2012 or 2011.
(d)
Amounts presented represent the effective portion of the gain or loss. For derivative financial instruments in cash flow hedge relationships, the effective portion is included in Other comprehensive income/(loss)–– unrealized holding gains/(losses) on derivative financial instruments. For derivative financial instruments in net investment hedge relationships and for foreign currency debt designated as hedging instruments, the effective portion is included in Other comprehensive income/(loss)––foreign currency translation adjustments.